|
SH3RF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.99631455600047E-13 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.535600E-01 |
| Stage1-vs-Stage3 |
5.464400E-01 |
| Stage1-vs-Stage4 |
3.71369999974114E-07 |
| Stage2-vs-Stage3 |
1.357170E-01 |
| Stage2-vs-Stage4 |
1.241740E-03 |
| Stage3-vs-Stage4 |
2.323500E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.75609999986115E-07 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
2.153400E-01 |
| Caucasian-vs-Asian |
2.802800E-01 |
| AfricanAmerican-vs-Asian |
1.248030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.301400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.408100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.011800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.166200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.407200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.175200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.329400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.609000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.24030000000242E-05 |
| Classical-VS-Follicular |
8.086400E-02 |
| Classical-VS-Other |
1.374240E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.09659999999001E-05 |
| Tall-VS-Other |
4.159400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.918350E-02 |
| Follicular-VS-Normal |
1.63546953757532E-12 |
| Other-VS-Normal |
1.67554858876429E-12 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
5.835900E-04 |
|
|
